Summary

On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic, and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 continues nearly 18 months later to present significant challenges to health systems and public health in both hemispheres, as well as the economies of every country. The morbidity and mortality of the infection caused by SARS-CoV-2 has been significant, and various waves of disease outbreaks initially overwhelmed many hospitals and clinics and continue to do so in many countries. This influences everyone, and public health countermeasures have been dramatic in terms of their impact on employment, social systems, and mental health. This entry collection aims to gather diverse fields about COVID-19, including in epidemiology, public health, medicine, genetics, systems biology, informatics, data science, engineering, sociology, anthropology, nursing, environmental studies, statistics, and psychology.

Expand All
Entries
Topic Review
The Corona Dashboard in Context (‘Dutchboard’)
The core corona dashboard depicts quantitative data—systemically decomposed—on key facts of the space and time spread of COVID-19 cases. There are three context-specific factors that determine the trajectory of the spread of the corona virus: (i) the degree of vaccination intensity in a given country; (ii) the policy stringency in coping with the virus; (iii) the degree of intensity of social contacts. 
  • 411
  • 04 Mar 2022
Topic Review
Motor and Cognitive Functions with Home-Confinement COVID-19
Distancing and confinement at home during the Coronavirus Disease 2019 (COVID-19) outbreak has led to worsening of motor and cognitive functions, both for healthy adults and for patients with neurodegenerative diseases. The decrease in physical activity, the cessation of the intervention of the recovery and the social distance imposed by the lockdown, has had a negative impact on the physical and mental health, quality of life, daily activities, as well as on the behavioral attitudes of the diet.
  • 344
  • 28 Feb 2022
Topic Review
Antivirals on the Cardiovascular Conditions
The COVID-19 pandemic has resulted in a complex clinical challenge, caused by a novel coronavirus, partially similar to previously known coronaviruses but with a different pattern of contagiousness, complications, and mortality. Safety profiles of antivirals are largely questioned and addressed by health agencies, in consideration of COVID-19 cardiac and pro-thrombotic complications generally experienced by predisposed subjects.
  • 694
  • 25 Feb 2022
Topic Review
Performance of Rapid Antigen Tests for COVID-19 Diagnosis
The identification of viral RNA using reverse transcription quantitative polymerase chain reaction (RT-qPCR) is the gold standard for identifying an infection caused by SARS-CoV-2. The limitations of RT-qPCR such as requirement of expensive instruments, trained staff and laboratory facilities led to development of rapid antigen tests (RATs). The performance of RATs has been widely evaluated and found to be varied in different settings. Although the sensitivity of RATs needs to be enhanced, it may still be a viable option in places where laboratory facilities are lacking for diagnostic purposes in the early phase of disease.
  • 370
  • 25 Feb 2022
Topic Review
Effect of COVID-19 on International Trade
The impact of the COVID-19 pandemic has been detrimental to all countries, despite the continuous efforts of governments on all continents to attempt to mitigate its damaging effects. All economic and social indicators have worsened. COVID-19 impact was evident in all countries, but not with the same strength.
  • 588
  • 18 Mar 2022
Topic Review
AKR1B10
Preventing the cytokine storm observed in COVID-19 is a crucial goal for reducing the occurrence of severe acute respiratory failure and improving outcomes. The analysis of transcriptomic data from lung samples of patients who died from COVID-19 demonstrates an increased expression of the gene encoding AKR1B10.
  • 393
  • 23 Feb 2022
Topic Review
Older Adults with Cancer and COVID-19
Older adults with cancer are amongst the most vulnerable population to be negatively impacted by COVID-19 due to their likelihood of comorbidities and compromised immune status. Considering the longevity of the pandemic, understanding the subjective perceptions and psychosocial concerns of this population may help ameliorate the psychological aftermath.
  • 552
  • 23 Feb 2022
Topic Review Peer Reviewed
Buddhism in Addiction Recovery
Buddhism was established by Guatama Buddha as a practice to liberate sentient beings from suffering. Mindfulness-Based interventions (MBIs) are Western psychologists’ adaptation of mindfulness/Vipassana to treat mental illnesses. In addition to mindfulness, Buddhist recovery peer-support programs also adopt the Four Noble Truths, the Noble Eightfold Path, and the Five Precepts, which are the Buddha’s prescription to cease suffering and to discipline one’s ethical conduct.
  • 1.3K
  • 13 Apr 2022
Topic Review
Leishmania for Developing a Novel Vaccine Platform
“Bugs as drugs” in medicine encompasses the use of microbes to enhance the efficacy of vaccination, such as the delivery of vaccines by Leishmania—the protozoan etiological agent of leishmaniasis. This novel approach is appraised in light of the successful development of vaccines for Covid-19. All relevant aspects of this pandemic are summarized to provide the necessary framework in contrast to leishmaniasis.
  • 427
  • 23 Feb 2022
Topic Review
Severe Thrombocytopenia as a Manifestation of COVID-19 Infection
Clinical manifestations of COVID-19 infection can range from an asymptomatic clinical form to acute respiratory distress depending on the virus gateway, viral load, host immunity, and existing comorbidities. Some patients with COVID-19 infection can present hematological changes depending on the patient’s immune response and the severity of the infection. Patients affected by the pandemic can develop platelet count changes such as thrombocytopenia. Thrombocytopenia can be detected in almost half of the patients infected by SARS-CoV-2 and in almost 95% of those critically ill.
  • 365
  • 22 Feb 2022
  • Page
  • of
  • 74
>>